The Effect of Heating the Intensive Care Room in the Early Postoperative Period on Patient Outcomes

NCT ID: NCT07137143

Last Updated: 2025-08-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-20

Study Completion Date

2025-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study was to evaluate the effect of heating the intensive care room in the early postoperative period on patient outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hypothermia is defined as a drop in body temperature below 35°C, and patients are at high risk during the perioperative period.Unintentional hypothermia can begin before anesthesia and continue for up to the first 24 hours postoperatively.Its incidence varies between 50% and 90% depending on the patient's medical condition, the nature of the surgery, and operating room conditions.Hypothermia leads to complications such as arrhythmia, hypertension, angina, coagulopathy, increased oxygen demand, nausea, vomiting, and delayed wound healing.Additionally, adverse effects such as shivering, changes in cognitive function, decreased patient comfort, and prolonged hospital stay are also observed.The development of hypothermia is influenced by anesthesia-related thermoregulation impairment, a cold operating room environment, and prolonged operations.Patients report experiencing intense chills and shivering, especially in the postoperative period.

This increases anxiety and negatively impacts patient satisfaction and comfort. Guidelines recommend the use of passive and active warming methods to prevent unintended hypothermia.However, no studies have been found in the literature examining the effect of heating the patient room in the postoperative period.In this regard, our study was designed to evaluate the effect of heating the intensive care room in the early postoperative period on patient outcomes and to contribute to the literature.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Abdominal Surgery Complications Hypothermia Following Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

2 groups, control group and intervention group
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

no intervention group

In the preoperative period, patients with a body temperature of 36°C-37°C one hour before surgery will be included in the sample. Postoperatively, upon arrival from the operating room to the intensive care unit, which has a humidity range of 55%-65% and a temperature range of 22°C-25°C, will be safely transferred to a single-bed room, monitored, and wiped down. After ensuring personal hygiene, the patient will be covered with a 160x220cm cotton quilt. The heating device hose will be placed inside the bed from the side of the bed. The electric heater will be operated at 38°C (Medium) for 120 minutes, 15 cm from the patient's body. Routine treatment and care will then be administered. Vital signs, shivering level, and temperature perception will be recorded on the patient's follow-up form at 0, 15, 30, 45, 60, 90, and 120 minutes postoperatively.

Group Type NO_INTERVENTION

No interventions assigned to this group

intervention group

In the preoperative period, patients with a body temperature of 36°C to 37°C one hour before surgery will be included in the sample. In the postoperative period, the intensive care room, which has a routine humidity range of 55%-65% and a temperature of 22°C to 25°C, will be heated to the upper limit of the intensive care room temperature range, 27°C, with an electric heater half an hour before the operation. After ensuring personal hygiene, the patient will be safely transferred to the bed in the single room, monitored, and wiped down. After ensuring personal hygiene, the patient will be covered with a 160x220cm cotton quilt. The heating device hose will be placed inside the bed from the edge of the bed. The electric heater will be operated at 38°C (Medium Level) for 120 minutes, 15cm from the patient's body. Routine treatment and maintenance will be administered. Then, the vital signs, pain, shivering level, and temperature perception will be recorded in the patient follow-up form a

Group Type EXPERIMENTAL

The rooms of the intervention group patients will be heated before they come to intensive care and the temperature of the room will be increased.

Intervention Type OTHER

The rooms of the intervention group patients will be heated before they come to intensive care and the temperature of the room will be increased.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

The rooms of the intervention group patients will be heated before they come to intensive care and the temperature of the room will be increased.

The rooms of the intervention group patients will be heated before they come to intensive care and the temperature of the room will be increased.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The following criteria will be included in the sample:
* Patients who underwent elective abdominal surgery and were admitted to intensive care after surgery.
* Patients aged 18 and over.
* Patients whose body temperature on the morning of surgery was neither below 36°C nor above 37.5°C.
* Patients who did not have a pacemaker, dementia, advanced spasticity, muscle atrophy, peripheral lesions, osteoporosis, skin irritation, diabetes, hypertension, or obesity.
* Patients who did not require mechanical ventilation.
* Patients who did not have any illness that would impair thermoregulation (such as head trauma or hypothalamic damage).

• Patients who were not taking medications that would affect thermoregulation, such as vasodilators.
* Patients who did not have peripheral circulation problems.
* Patients who were not alcohol or substance abusers.
* Patients who did not have mental retardation.
* Patients who were conscious and oriented to person, time, and place.
* Patients who could speak Turkish.
* Patients who did not have any auditory or visual impairments.
* Patients who volunteered for the study.

Exclusion Criteria

* Patients who do not meet the sampling criteria, who develop postoperative complications (bleeding, intubation, stenosis, necrosis, ileus, dermatitis, parastomal herniation, etc.), and whose relatives do not consent to the study will not be included in the study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cukurova University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Cansel Bozer

expert

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Adana City Training and Research Hospital

Adana, Yüreğir, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Cansel Bozer Uludağ, expert

Role: CONTACT

+905434332624

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Cansel Bozer Uludağ, Expert

Role: primary

+905434332624

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CU-SBF-CB-05

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.